Medical Technologies Guidance MTG54

NICE conclude that the VAC Veraflo Therapy system shows promise for treating acute infected or chronic wounds that are not healing. However there is not enough good-quality evidence to support the case for routine adoption. Although there are potential benefits for patients and the NHS, more evidence is needed to be certain of VAC Veraflo Therapy system’s clinical effectiveness and potential for cost savings compared with negative pressure wound therapy

Classifications: Breast & Oncoplastic Surgery

Keywords: Negative Pressure Wound Dressings